SCHEMBL5134967

SCHEMBL5134967

CCCCn1c(CN(Cc2ccc3c(c2)OCO3)Cc2c(F)cc(F)cc2F)cnc1-c1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.46
HSP90AA1 P07900 2/20 0.39
HSP90AB1 P08238 2/20 0.39
F2R P25116 3/20 0.38
CTSL P07711 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
UBE2M P61081 2/20 0.36
DCUN1D1 Q96GG9 2/20 0.36
KDM4E B2RXH2 2/20 0.35
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
THRB P10828 1/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
CASP1 P29466 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5134690 0.94 C5AR1 (0.47) C5AR1HSP90AA1HSP90AB1F2RCTSL
SCHEMBL5135969 0.94 C5AR1 (0.53) C5AR1HSP90AA1HSP90AB1F2RCTSL
SCHEMBL4766728 0.94 C5AR1 (0.51) C5AR1HSP90AA1HSP90AB1F2RCTSL
SCHEMBL5135119 0.92 C5AR1 (0.45) C5AR1HSP90AA1HSP90AB1F2RCTSL
SCHEMBL5135741 0.91 C5AR1 (0.48) C5AR1HSP90AA1HSP90AB1F2RCTSL
SCHEMBL5147409 0.90 C5AR1 (0.54) C5AR1HSP90AA1HSP90AB1F2RCTSL
SCHEMBL5136147 0.90 C5AR1 (0.47) C5AR1HSP90AA1HSP90AB1F2RCTSL
SCHEMBL5149996 0.90 C5AR1 (0.49) C5AR1HSP90AA1HSP90AB1F2RCTSL
SCHEMBL5136076 0.89 C5AR1 (0.49) C5AR1HSP90AA1HSP90AB1F2RCTSL
SCHEMBL5137625 0.89 C5AR1 (0.47) C5AR1HSP90AA1HSP90AB1F2RCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed